Seven Oral Presentations: Innovent to Present Breakthrough Clinical Data of IBI363（PD-1/IL-2α-bias）and Other Novel Drug Candidates at the 2025 ASCO Annual Meeting
SAN FRANCISCO and SUZHOU,China, April 24, 2025 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of oncology, cardiovascular and metabolic, autoimmune, ophthalmology and other major diseases, announces that clinical data for its innovative bispecific antibodies and ADC molecules, including oral presentations for IBI363 (PD-1/IL-2α-bias)...
CGBIO Receives FDA IDE Approval for NOVOSIS PUTTY, Advancing Toward U.S. Market Entry
- The bone graft incorporating rhBMP-2 has received FDA IDE approval for a pivotal clinical trial in spinal fusion- Positioned for global expansion in $750M spinal bone graft market SEOUL, South Korea, April 24, 2025 /PRNewswire/ -- CGBIO(CEO Hyun Seung Yu), a leading Korean company specializing in bio-regenerative medicine, proudly announces that its innovative bone graft...
SimonMed Imaging Partners with Lunit to Deliver Best-in-Class AI for Breast Cancer Detection
A Major Leap Forward in Patient Health and the Future of Mammography PHOENIX, April 24, 2025 /PRNewswire/ -- SimonMed Imaging®, one of the largest and most advanced outpatient medical imaging providers in the United States, is proud to announce their partnership with Lunit, a global leader in AI-driven cancer diagnostics and therapeutics,...
Call for Nominations: Seventh Annual .ORG Impact Awards to Recognize Global Changemakers
PIR increases age limit of "Rising Star" category from 25 to under 30 Winners eligible for prize donations up to $50,000 USD out of $180,000 USD total prize awards RESTON, Va., April 23, 2025 /PRNewswire/ -- Public Interest Registry (PIR), the nonprofit stewards of the .ORG domain, today opened the nomination period for its...
LakeShore Biopharma Announces the Official Launch of a Novel Packaging Solution for YSJA™ Rabies Vaccine (Vero Cell)
Revolutionizing Vaccination Safety with Needle-Free Reconstitution Technology BEIJING, April 23, 2025 /PRNewswire/ -- On April 18, 2025, LakeShore Biopharma Co., Ltd. (Nasdaq: LSB) ("LakeShore Biopharma" or the "Company") successfully held the 2025 CSO ("Contract Sales Organization") Annual Meeting and the launch meeting of YSJA™ rabies vaccine (Vero cell) novel packaging solution (liquid drug transfer device) in Changsha, Hunan Province. Approved for lot release...
FIELD MEDICAL ANNOUNCES FIRST-IN-HUMAN DATA FOR FOCAL PFA IN SCAR-RELATED VT AT HEART RHYTHM 2025
Eight presentations, including late-breaking science, live cases, and a landmark symposium CARDIFF-BY-THE-SEA, Calif., April 23, 2025 /PRNewswire/ -- Field Medical Inc., a leader in cardiac pulsed field ablation (PFA) technology, announced today its FieldForce™ Ablation System will be featured in eight scientific presentations at the 46th annual Heart Rhythm Society (HRS)...
Sengkang General Hospital Introduces Photon-Counting CT Scanner to Advance Diagnostic Capabilities
New photon-counting CT scanner aims to enhance diagnostic imaging capabilities for SKH. Advanced technology provides clearer images with lower radiation dose, improving diagnostic precision and patient safety. SINGAPORE, April 23, 2025 /PRNewswire/ -- Sengkang General Hospital (SKH) officially launched a new photon-counting computed tomography (CT) scanner today, strengthening its imaging...
Tsingke Gene Leads a Delivery Revolution with “Calendar Day Delivery”
BEIJING, April 23, 2025 /PRNewswire/ -- In March 2025, Tsingke pioneered the industry's first full-range "Calendar Day Delivery" model, redefining standards for gene synthesis services through a comprehensive suite of offerings such as Tsynth™Gene Synthesis, PCR Cloning & Subcloning, Site-directed Mutagenesis, Plasmid Preparation, and more, tailored to diverse research needs. As the first gene synthesis company to publicly commit to "calendar...
Clarivate Launches DRG Commercial Analytics 360 Enabling Medtech Companies to Advance Commercial Strategy and Execution
New solution provides integrated provider intelligence and real-world data to optimize targeting, strategic planning and patient access across commercial organizations LONDON, April 23, 2025 /PRNewswire/ -- Clarivate Plc (NYSE: CLVT), a leading global provider of transformative intelligence, today announced the launch of DRG Commercial Analytics 360—a solution designed to empower medtech companies with...
A Breakthrough in Brain Surgery Monitoring: Guarding Lives with Raytron’s Thermal Imaging Technology
YANTAI, China, April 23, 2025 /PRNewswire/ -- In high-stakes neurosurgery, gaining real-time insights into cerebral blood flow is vital yet challenging. Conventional indocyanine green (ICG) fluorescence imaging relies on contrast agents and offers limited repeatability. Now, infrared thermography cameras promise a non-contact, contrast-free, radiation-free, and non-invasive diagnostic imaging alternative, delivering continuous monitoring that enhances surgical precision and patient safety....
